Skip to main content
. 2023 Jul 14;18(7):e0288286. doi: 10.1371/journal.pone.0288286

Table 1. Baseline characteristics of study participants.

Characteristic Total (n = 60) NWG (n = 30) OWG (n = 30) p-value
Age (year) 30± 9.00 27 ± 7.50 33 ± 9.48 0.008*
Gender (male/female) 30/30 15/15 15/15 1.000
Height (cm) 167.00 ± 8.36 167.20 ± 8.12 166.80 ± 8.72 0.891
Weight (kg) 68.78 ± 13.75 58.88 ± 5.76 78.68 ± 12.20 < 0.001*
BMI (kg/m2) 24.68 ± 4.65 21.08 ± 1.38 28.28 ± 3.92 < 0.001*
SBP (mmHg) 119 ± 12 114 ± 13 124 ± 10 0.003*
DBP (mmHg) 77 ± 10 75 ± 8 79 ± 10 0.074
BFM (kg) 20.29 ± 9.93 13.00 ± 4.96 27.57 ± 8.14 < 0.001*
% BF 28.30 ± 10.49 21.94 ± 8.41 34.66 ± 8.32 < 0.001*
SM (kg) 27.08 ± 5.77 25.51 ± 4.55 28.64 ± 6.47 0.034*
TC (mg/dL) 198.67 ± 37.23 200.90 ± 32.80 196.43 ± 41.64 0.646
LDL-C (mg/dL) 132.69 ± 37.39 131.12 ± 32.06 134.26 ± 42.55 0.748
HDL-C (mg/dL) 52.89 ± 12.59 58.63 ± 10.57 47.33 ± 12.04 < 0.001*
TC (mg/dL) 102.42 ± 65.00 82.43 ± 60.98 122.40 ± 63.65 0.016*
FBG (mg/dL) 85.40 ± 7.12 85.87 ± 6.11 84.93 ± 8.08 0.616
CRP (mg/dL) 2.18 ± 3.57 0.69 ± 0.78 3.67 ± 4.55 < 0.001*
BUN(mg/dL) 12.55 ± 3.30 13.40 ± 3.49 11.70 ± 2.91 0.045*
CRE (mg/dL) 0.81 ± 0.18 0.85 ± 0.18 0.78 ± 0.18 0.126
INS (μU/mL) 9.23 ± 5.55 6.68 ± 2.42 11.77 ± 6.58 < 0.001*
SGOT (U/mL) 24.25 ± 23.69 0.22 ± 0.04 0.22 ± 0.37 0.665
SGPT (U/mL) 25.05 ± 20.13 22.00 ± 17.58 28.10 ± 22.27 1.000

Data are presented as mean ± standard deviation or n (%).

*p-value for differences between the overweight group (OWG) and normal weight group (NWG) by t-test for continuous variables (p<0.05). Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; BFM, body fat mass; BF, body fat; SM, skeletal muscle mass; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TC, triglyceride; FBG, fasting blood glucose; CRP, c-reactive protein; BUN, blood urea nitrogen; CRE, Creatinine; INS, Insulin; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamate pyruvate transaminase.